Results 121 to 130 of about 1,115,446 (258)

ABO blood group screening results among blood donors in Guangzhou from 2021 to 2022

open access: yesZhongguo shuxue zazhi
Objective To investigate the distribution of ABO and RhD blood groups among voluntary blood donors in Guangzhou, in order to ensure clinical blood safety and better serve blood donors.
Xuying LIU   +8 more
doaj   +1 more source

ABO Blood Groups and Secretor Character in Rheumatic Carditis [PDF]

open access: green, 1960
Cyril Clarke   +2 more
openalex   +1 more source

ABO and Rhesus (D) Blood Group Distribution among Nigerians in Ojo Area, Lagos State, Nigeria

open access: yesSokoto Journal of Medical Laboratory Science, 2016
ABO and Rhesus blood groups are known to vary from one population to another. They are the most clinically significant and prevalent blood group systems. Their relevance in blood transfusion science cannot be over emphasized.
Odegbemi, O.B., Atang, E.B., Atapu, D.A., Jonathan, J.P., Okunola, O.A., Festus, O., Odegbemi, A.O.
doaj  

Comparison of printed glycan array, suspension array and ELISA in the detection of human anti-glycan antibodies [PDF]

open access: yes, 2018
Anti-glycan antibodies represent a vast and yet insufficiently investigated subpopulation of naturally occurring and adaptive antibodies in humans. Recently, a variety of glycan-based microarrays emerged, allowing high-throughput profiling of a large ...
Bovin, Nicolai   +9 more
core  

B/O blood group chimera identified by PacBio third-generation sequencing: a case report

open access: yesZhongguo shuxue zazhi
[Objective] To determine the blood group of a patient with ABO forward and reverse typing discrepancies using PacBio third-generation sequencing (TGS) technology, and to explore the application of serological methods and molecular biological methods in ...
LI Ruirui, CUI Congcong, HAO Xiao
doaj   +1 more source

Changing perspectives on liver transplantation in 1988. [PDF]

open access: yes, 1988
After liver transplantation for cancer, there is a high incidence of disease recurrence within 18 to 36 months for most tumors, although there are a small number of long-term survivors.
Gordon, RD, Starzl, TE
core  

Home - About - Disclaimer - Privacy